Join
Live feed
·
SECFilingvia Quantisnow
Adaptimmune Therapeutics plc logo

Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

ByQuantisnow·Wall Street's wire, on your screen.
ADAP· Adaptimmune Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.

Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | Quantisnow